Anthem Biosciences reported a 3.05% stake sale through open market transactions on Thursday, with a consortium of foreign and domestic institutional investors purchasing the shares, as per a PTI news report.
According to NSE block deal data, 1,71,14,604 shares changed hands at an average price of ₹744.80 per share, taking the total transaction value to ₹1,274.69 crore.
The buying consortium included Societe Generale, Prudential Hong Kong and Ghisallo Capital Management. Other overseas participants were Nordea Asset Management, Integrated Core Strategies Asia Pte Ltd and Social Protection Fund.
Domestic investors also took part in the transaction. These included SBI Mutual Fund, HDFC Mutual Fund, Kotak Mahindra Mutual Fund, UTI Mutual Fund, Edelweiss Mutual Fund, Canara Robeco Mutual Fund, 360 ONE Mutual Fund, Mahindra Manulife Mutual Fund and WhiteOak Capital Mutual Fund.
The shares were sold by promoter Aruna Ganesh through the block deal. Following the transaction, the combined shareholding of the promoter and promoter group declined to 71.63% from 74.68%.
PI Opportunities AIF V LLP, an affiliate of Premji Invest, along with Kotak Mahindra Life Insurance, Bajaj Life Insurance and ICICI Prudential Life Insurance, were also among the buyers in the transaction.
Anthem Biosciences operates as an integrated Contract Research, Development and Manufacturing Organisation (CRDMO), providing research, development and manufacturing services to pharmaceutical and biotechnology companies.
As of 19 June 2026, 12:47 pm, Anthem BioSciences Ltd share price was trading at ₹793.50, down 0.58% from the previous closing price.
The block deal resulted in a 3.05% stake in Anthem Biosciences changing hands, with institutional investors emerging as buyers. Following the transaction, the promoter group's holding declined to 71.63%.
For daily market updates and regular stock market news in Hindi, stay tuned to Angel One's share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jun 19, 2026, 1:15 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
